Hypertensive Urgency Management Guidelines

Classification of the Presentation

A blood pressure of 170/110 mmHg with orthostatic dizziness, mild headache, and no evidence of acute target‑organ damage is classified as hypertensive urgency, which can be treated with oral antihypertensives and outpatient follow‑up rather than hospital admission. 1
The distinction between hypertensive urgency and emergency is based on the presence or absence of acute target‑organ injury, not on the absolute blood pressure value. 1

A normal neurologic examination (GCS 15, no altered mental status, no focal deficits) effectively excludes hypertensive encephalopathy. 2
Absence of chest pain, dyspnea, pulmonary edema, and a regular cardiac rhythm without murmurs rules out acute cardiac involvement. 2
Lack of oliguria (with baseline renal function pending) suggests no overt renal failure. 2
Dilated fundoscopy is essential to exclude malignant hypertension (e.g., bilateral retinal hemorrhages, cotton‑wool spots, papilledema); detection of such findings would reclassify the case as a hypertensive emergency. 2

Extended‑release nifedipine 30 mg PO is recommended as the first‑line oral agent for rapid but controlled BP reduction in hypertensive urgency. 2
If nifedipine is contraindicated, captopril 12.5–25 mg PO may be used, with caution for abrupt BP drops in volume‑depleted patients. 2
Oral labetalol 200 mg PO is an alternative when calcium‑channel blockers are unsuitable, avoiding use in patients with reactive airway disease, heart block, or bradycardia. 2
Immediate‑release nifedipine should be avoided because it can cause unpredictable precipitous BP falls, increasing the risk of stroke and death. 2

Aim for a gradual reduction to <160/100 mmHg within the first 24–48 h, then to <130/80 mmHg over the ensuing weeks. 1
Rapid BP lowering is discouraged in chronic hypertensives because it may precipitate cerebral, renal, or coronary ischemia due to altered autoregulation. 1
After oral medication administration, observe the patient for at least 2 hours to assess efficacy and safety. 2

Initiate combination therapy in patients not previously on maintenance drugs:
- ACE inhibitor or ARB (e.g., losartan 50 mg daily, titrate to 100 mg).
- Thiazide diuretic (hydrochlorothiazide 12.5 mg daily, increase to 25 mg after 2–4 weeks if needed).
- Add a dihydropyridine calcium‑channel blocker (amlodipine 5–10 mg daily) if BP remains >130/80 mmHg. 1
Re‑check a basic metabolic panel 2–4 weeks after starting a thiazide to monitor electrolytes and renal function. 2

Smoking cessation, sodium restriction to <2 g/day, weight management, moderate alcohol intake, and regular aerobic exercise (≥150 min/week) are recommended to support BP control. 1

Schedule an outpatient visit within 2–4 weeks to review BP, laboratory results, and medication tolerance. 1
Continue monthly visits until the target BP of <130/80 mmHg is consistently achieved. 1
Instruct the patient to perform home BP monitoring twice daily, aiming for a home reading <130/80 mmHg. 2

Perform targeted investigations for secondary causes given severe, untreated hypertension in a relatively young adult:
- Renal artery stenosis – renal ultrasound with Doppler.
- Primary aldosteronism – aldosterone‑to‑renin ratio.
- Pheochromocytoma – 24‑hour urine metanephrines.
- Renal parenchymal disease – assessment via serum creatinine and urinalysis. 2
Approximately 20–40 % of patients with malignant hypertension have an identifiable secondary etiology. 2

New or worsening severe headache with vomiting or altered mental status (possible encephalopathy).
Visual loss or disturbances (cortical blindness or retinal damage).
Chest pain or severe dyspnea (acute coronary syndrome or pulmonary edema).
Focal neurologic deficits or seizures (stroke).
Sudden severe back or abdominal pain (aortic dissection).

Do not admit patients with hypertensive urgency and no target‑organ damage; outpatient management is appropriate. 1
Do not use IV antihypertensives for urgency; oral agents are sufficient. 1
Do not rapidly lower BP beyond the recommended gradual targets, as this can cause ischemic complications. 1
Do not discharge without fundoscopy; missing malignant hypertension would be a critical error. 2
Do not assume orthostatic dizziness is benign; it may reflect volume depletion from pressure natriuresis, influencing ACE‑inhibitor use. 2

Discharge with extended‑release nifedipine 30 mg PO daily, outpatient follow‑up in 2–4 weeks, home BP monitoring instructions, and a written list of red‑flag symptoms. 1